Docoh
Loading...

GSK Glaxosmithkline

News

Pro users get this 30m faster
BioSig Technologies Says Invited To Join Alliance For Artificial Intelligence In Healthcare
9 Apr 21
News, FDA
BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH) Westport, CT, April 09, 2021 (GLOBE NEWSWIRE) -- Global leaders, including Amazon, Bayer, and GE Healthcare, joined the AAIH to date to
Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC
8 Apr 21
Biotech, Government, News, Health Care, FDA, General
Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots
7 Apr 21
Biotech, Government, News, Health Care, FDA, Top Stories, Media, General
The European Medicines Agency (EMA), after an in-depth analysis, has concluded that unusual blood clots should be listed&nbs
Vir Biotech's VIR-7831 Maintains Activity Against California Variant Of COVID-19 Infection
5 Apr 21
Biotech, News, Health Care, FDA, General
Royalty Pharma Buys Royalty Interest In Cabozantinib Products From GSK
1 Apr 21
Biotech, M&A, News, Health Care, Contracts, General
EMA May Issue Updated Recommendation If AstraZeneca Jab-Clot Link Is Established: Report
31 Mar 21
Biotech, Government, News, Health Care, Contracts, FDA, General
The European Medical Agency (EMA) said there could be a possible link between AstraZeneca&
Pfizer-BioNTech's COVID-19 Vaccine Gives 100% Protection In Adolescents
31 Mar 21
Biotech, News, Health Care, FDA, General
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ:
CureVac Taps Celonic For COVID-19 Vaccine Production
30 Mar 21
Biotech, News, Health Care, Contracts, General
The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings
30 Mar 21
Biotech, Earnings, News, Penny Stocks, Offerings, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 29)
Glaxo To Fill About 60M Novavax COVID-19 Shots For Britain
29 Mar 21
Biotech, Government, News, Health Care, Contracts, General
GlaxoSmithKline Plc (NYSE: GSK) has
Novavax Shares Spiked Higher Before Reversing Course, Following Report GlaxoSmithKline To Manufacture 60M Doses Of Novavax COVID-19 Vaccine In UK
29 Mar 21
News
https://www.ft.com/content/55f1776f-84bb-45bd-83cc-bdc825817879
Eli Lilly-Vir Bamlanivimab-VIR-7831 Combo Reduces Viral Load By 70% In Low-Risk COVID-19 Patients
29 Mar 21
Biotech, News, Health Care, FDA, General
Eli Lilly And Co (NYSE: LLY), Vir Biotechnology Inc (NASDAQ:
What Does GlaxoSmithKline's Debt Look Like?
29 Mar 21
News, Intraday Update, Markets
Shares of GlaxoSmithKline (NYSE:GSK) fell by 1.41% in the past three months. Before having a look at the importance of debt, let us look at how much debt GlaxoSmithKline has.
Lilly, Vir Biotechnology And GSK Announce Topline Data From Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab With VIR-7831 In Low-Risk Adults With COVID-19; Trial Met Primary Endpoint
29 Mar 21
Eli Lilly and Company (NYSE:LLY), Vir Biotechnology, Inc. (NASDAQ:VIR) and GlaxoSmithKline plc (NYSE:GSK) today announced topline data from the expanded Phase 2 BLAZE-4 trial studying low-risk adult patients with mild to
White House Contemplates Waiving-Off Patent Protections For COVID-19 Treatments
29 Mar 21
Biotech, Government, News, Health Care, FDA, General
Amid rising pressure from developing countries, the White House is reportedly contemplating suspension of intellectual property protections
GlaxoSmithKline, Vir Biotechnology Seek Emergency FDA Authorization For COVID-19 Drug
26 Mar 21
Biotech, News, Health Care, FDA, General
GlaxoSmithKline plc (NYSE: GSK) and Vir Biotechnology Inc. (NASDAQ: VIR) have submitted an application to the Food and Drug Administration requesting emergency use authorization for VIR-7831, an investigational dual-ac
GSK Fires Moncef Slaoui Over Sexual Harassment Charges
24 Mar 21
Biotech, News, Health Care, Management, General
Moncef Slaoui, former chief scientist of Operation Warp Speed during the Trump administration, was fired as Galvani Bioelectronics’ board chairm
Pfizer Plans To Develop New mRNA-Based Vaccines By Itself, Says CEO: WSJ
23 Mar 21
Biotech, News, Health Care, FDA, General
Pfizer Inc’s (NYSE: PFE) chief executive Albert Bourla said that the company
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2021
23 Mar 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
SVB Leerink Downgrades GlaxoSmithKline to Market Perform
23 Mar 21
News, Downgrades, Analyst Ratings
SVB Leerink analyst Geoffrey Porges downgrades GlaxoSmithKline (NYSE:GSK) from Outperform to Market Perform.

Press releases

Pro users get this 30m faster
BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)
9 Apr 21
Health Care, Press Releases
Westport, CT, April 09, 2021 (GLOBE NEWSWIRE) -- Global leaders, including Amazon, Bayer, and GE Healthcare, joined the AAIH to date to collaborate on developing novel solutions to improve the quality of care and
Flonase teams up with Major League Baseball and World Series champion Cody Bellinger to change the game on allergy season
1 Apr 21
Press Releases
WARREN, N.J., April 1, 2021 /PRNewswire/ -- GSK Consumer Healthcare (LSE/NYSE: GSK) announced today that Flonase Allergy Relief (Flonase) is partnering with World Series champion and seasonal allergy-sufferer Cody
Flonase teams up with Major League Baseball and World Series champion Cody Bellinger to change the game on allergy season
1 Apr 21
Press Releases
WARREN, N.J., April 1, 2021 /PRNewswire/ -- GSK Consumer Healthcare (LSE/NYSE: GSK) announced today that Flonase Allergy Relief (Flonase) is partnering with World Series champion and seasonal allergy-sufferer Cody
Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19
29 Mar 21
Press Releases
INDIANAPOLIS and SAN FRANCISCO and LONDON, March 29, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY), Vir Biotechnology, Inc. (NASDAQ:VIR) and GlaxoSmithKline plc (NYSE:GSK) today announced topline data from the
GSK and Vir Biotechnology Announce Submission of Emergency Use Authorization Request to FDA for VIR-7831 for the Early Treatment of COVID-19
26 Mar 21
Press Releases
LONDON and SAN FRANCISCO, March 26, 2021 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (NYSE:GSK) and Vir Biotechnology, Inc. (NASDAQ:VIR) today announced the submission of an application to the U.S. Food and Drug
Effective Diagnostics Help to Tame the Spread of the Pandemic
24 Mar 21
Small Cap, Opinion, Press Releases
NEW YORK, March 24, 2021 /PRNewswire/ -- Recent reports from across the country clearly show that infection cases are stabilizing. Additionally, vaccines are being administrated at an effective rate, which contributes to
Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK for the Advancement of Multiple Pre-Phase 2 Programs
18 Mar 21
Press Releases
- The first two programs selected under the agreement are for oncology and CNS disorders - Boston Pharmaceuticals announced today a pioneering three-year out-license and option agreement with GlaxoSmithKline PLC
Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19
10 Mar 21
Health Care, Press Releases, General
– Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or death – – Vir and GSK plan to immediately seek Emergency Use Authorization in the
MorphoSys's Licensing Partner GSK Shared Preliminary Results From OSCAR Study with Otilimab for the Treatment of Severe Pulmonary COVID-19 Related Disease; Expanding the Study for Patients 70 Years and Older
2 Mar 21
Biotech, News, Press Releases
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / March 2, 2021 / MorphoSys AG ((FSE:MOR, Prime Standard Segment, MDAX &, TecDAX, NASDAQ:MOR), a commercial-stage biopharmaceutical company and a leader in antibody, protein and
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
17 Feb 21
News, Contracts, Press Releases
– Companies applying their combined expertise in immunology and infectious diseases to accelerate the development of promising monoclonal antibody candidates for influenza – – Functional genomics collaboration expanded
TUMS Expands Portfolio to Meet Consumer Demands for Naturally-Sourced Products
16 Feb 21
Press Releases
WARREN, N.J., Feb. 16, 2021 /PRNewswire/ -- GSK Consumer Healthcare (LSE/NYSE: GSK) today announced the launch of TUMS Naturals, a new naturally-powered antacid joining the TUMS portfolio. As America's #1 heartburn
GSK and CureVac to Develop Next Generation MRNA COVID-19 Vaccines
3 Feb 21
Contracts, Press Releases
Companies aim to develop a multi-valent candidate vaccine to address emerging variants for pandemic and endemic useDevelopment to begin immediately targeting vaccine availability in 2022, subject to regulatory
TUMS® Kicks Off $55,000 #TUMSBingoSweepstakes for the BIG GAME
1 Feb 21
Press Releases
WARREN, N.J., Feb. 1, 2021 /PRNewswire/ -- GlaxoSmithKline (LSE: GSK) (NYSE:GSK) – This year, the #TUMSBingoSweepstakes is the BIG GAME within the BIG GAME and takes place on a day known for indulging in
Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19
27 Jan 21
Press Releases
INDIANAPOLIS and SAN FRANCISCO and LONDON, Jan. 27, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY), Vir Biotechnology, Inc. (NASDAQ:VIR) and GlaxoSmithKline plc (NYSE:GSK) today announced a collaboration to
Lilly, Vir Biotechnology and GSK Announce First Patient Dosed in Expanded BLAZE-4 Trial Evaluating Bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19
27 Jan 21
Biotech, Press Releases, General
INDIANAPOLIS, SAN FRANCISCO and LONDON, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Eli Lilly and Company (NYSE:LLY), Vir Biotechnology, Inc. (NASDAQ:VIR) and GlaxoSmithKline plc (NYSE:GSK) today announced a collaboration to
Consumers Continue Flocking to Immune-Boosting Supplements as Health Crisis Rage On
25 Jan 21
Opinion, Press Releases
FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Jan. 25, 2021 /PRNewswire/ -- The health crisis has completely changed life as we know it and caused a significant shift in consumer demand for
Vir Biotechnology and GSK Announce NHS-Supported AGILE Study to Evaluate VIR-7832 in the Early Treatment of COVID-19
12 Jan 21
Press Releases
Second monoclonal antibody from Vir-GSK collaboration to be investigated as a potential COVID-19 treatmentPreclinical data suggest VIR-7832 has two distinguishing properties: enhanced ability to clear infected cells and